Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma

Genes Chromosomes Cancer. 2013 Jun;52(6):523-37. doi: 10.1002/gcc.22049. Epub 2013 Mar 5.

Abstract

Gene organization in nonmalignant B cells from t(4;14) and t(11;14) multiple myeloma (MM) patients differs from that of healthy donors. Among recurrent IGH translocations in MM, the frequency of t(4;14) (IGH and FGFR3) or t(11;14) (IGH and CCND1) is greater than the frequency of t(14;16) (IGH and MAF). Gene organization in t(14;16) patients may influence translocation potential of MAF with IGH. In patients, three-dimensional FISH revealed the positions of IGH, CCND1, FGFR3, and MAF in nonmalignant B cells that are likely similar to those when MM first arose, compared with B cells from healthy donors. Overall, IGH occupies a more central nuclear position while MAF is more peripherally located. However, for B cells from t(4;14) and t(11;14) patients, IGH and FGFR3, or IGH and CCND1 are found in spatial proximity: IGH and MAF are not. This differs in B cells from t(14;16) patients and healthy donors where IGH is approximately equidistant to FGFR3, CCND1, and MAF, suggesting that gene organization in t(14;16) patients is different from that in t(4;14) or t(11;14) patients. Translocations between IGH and MAF may arise only in the absence of close proximity to the more frequent partners, as appears to be the case for individuals who develop t(14;16) MM.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / metabolism
  • B-Lymphocytes / pathology*
  • Biomarkers, Tumor / genetics*
  • Chromosomes, Human, Pair 11 / genetics*
  • Chromosomes, Human, Pair 14 / genetics*
  • Chromosomes, Human, Pair 16 / genetics*
  • Chromosomes, Human, Pair 4 / genetics*
  • Genetic Loci
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • In Situ Hybridization, Fluorescence
  • Multiple Myeloma / genetics*
  • Oncogene Proteins, Fusion / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Proto-Oncogene Proteins c-maf / genetics
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Translocation, Genetic / genetics*

Substances

  • Biomarkers, Tumor
  • IGH-CCND1 fusion protein, human
  • Immunoglobulin Heavy Chains
  • MAF protein, human
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins c-maf
  • RNA, Messenger
  • Receptors, Transforming Growth Factor beta
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II